Characteristics | Total-USC (n = 91) | Pure-USC (n = 60) | Mixed-USC (n = 31) | P-Value |
---|---|---|---|---|
TP53-abnormity | 0.759 | |||
Yes | 77(88.5%) | 50 (89.3%) | 27 (87.1%) | |
no | 10(11.5%) | 6 (10.7%) | 4 (12.9%) | |
unknown | 4 | 4 | 0 | |
ER | 0.352 | |||
positive | 47(52.2%) | 28 (47.5%) | 19 (61.3%) | |
negative | 43(47.8%) | 31 (52.4%) | 12 (38.7%) | |
unknown | 1 | 1 | 0 | |
PR | < 0.001 | |||
positive | 35(38.9%) | 14 (23.7%) | 21 (67.7%) | |
negative | 55(61.1%) | 45 (76.3%) | 10 (32.3%) | |
unknown | 1 | 1 | 0 | |
SEIC | 0.172 | |||
yes | 12(13.2%) | 10 (16.7%) | 2 (6.5%) | |
no | 79(86.8%) | 50 (83.3%) | 29 (93.5%) | |
Myometrial invasion depth | 0.187 | |||
<1/2 | 53(58.2%) | 32 (53.3%) | 21 (67.7%) | |
≥ 1/2 | 38(41.8%) | 28 (46.7%) | 10 (32.3%) | |
LVSI | 0.719 | |||
Yes | 43(47.8%) | 29 (49.2%) | 14 (45.2%) | |
no | 47(52.2%) | 30 (50.8%) | 17 (54.8%) | |
unknown | 1 | 1 | 0 | |
Lymph nodes metastasis | 0.053 | |||
yes | 29(34.5%) | 23 (41.8%) | 6 (20.7%) | |
no | 55(65.5%) | 32 (58.2%) | 23 (79.3%) | |
unknown | 7 | 5 | 2 | |
Peritoneal cytology | 0.046 | |||
Yes | 21(30.0%) | 17 (37.8%) | 4 (15.4%) | |
no | 50(70.4%) | 28 (62.2%) | 22 (84.6%) | |
unknown | 20 | 15 | 5 |